Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease

✍ Scribed by Tomoya Fukui; Sakiko Otani; Ryuji Hataishi; Shi-Xu Jiang; Yasuto Nishii; Satoshi Igawa; Hisashi Mitsufuji; Masaru Kubota; Masato Katagiri; Noriyuki Masuda

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 548 KB
• Volume: 65
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-1212-5